Excerpt: “Today, the CMS Innovation Center announced changes to its model portfolio to align with its statutory obligation and strategic goals. Innovation Center Models are time-limited experiments that provide a controlled environment to determine, through rigorous evaluation, what approaches should be expanded nationwide, what specific components of an approach need further testing in successor models and what approaches are not viable for expansion. As is the nature of innovation, not every model will work, and the Center must be efficient and effective in its response. The Center regularly assesses and may amend model activities in response to a model’s projected savings, quality outcomes data, legal compliance, operational feasibility and gaps in expected versus actual impact. The Center aims to end these models early, by December 31, 2025. Most models selected for early termination are within 2 years of their end date. Models Identified to End Early (Original Performance Period)
- Maryland Total Cost of Care (2019 – 2026)
- Primary Care First (2021 – 2026)
- ESRD Treatment Choices (2021 – 2027; will propose termination through rulemaking)
- Making Care Primary (2024 – 2034)
CMS is considering options to reduce the size of the Integrated Care for Kids (2020 – 2026) awards or make other changes to the model. Further, the CMS Innovation Center will no longer pursue two previously announced but not yet implemented models given the flexibility provided by President Trump’s rescission of Executive Order 14087 on January 20, 2025:
- Medicare $2 Drug List
- Accelerating Clinical Evidence
… Based on an analysis of published evaluation reports and financial forecasting, CMS estimates a savings of almost $750,000,000 by ending the selected models early.”
Share